Department of Pathology, Virginia Commonwealth University, Richmond, VA; SydPath, St. Vincent's Hospital, Sydney, Australia; and University of New South Wales, Kensington, NSW, Australia.
Department of Pathology, Virginia Commonwealth University, Richmond, VA; SydPath, St. Vincent's Hospital, Sydney, Australia; and University of New South Wales, Kensington, NSW, Australia.
Adv Chronic Kidney Dis. 2018 Jan;25(1):7-13. doi: 10.1053/j.ackd.2017.09.013.
In 2002, the Kidney Disease Outcomes Quality Initiative guidelines for identifying and treating CKD recommended that clinical laboratories report estimated glomerular filtration rate (eGFR) with every creatinine result to assist clinical practitioners to identify people with early-stage CKD. At that time, the original Modification of Diet in Renal Disease (MDRD) Study equation based on serum creatinine measurements was recommended for calculating eGFR. Because the MDRD Study equation was developed using a nonstandardized creatinine method, a Laboratory Working Group of the National Kidney Disease Education program was formed and implemented standardized calibration traceability for all creatinine methods from global manufacturers by approximately 2010. A modified MDRD Study equation for use with standardized creatinine was developed. The Chronic Kidney Disease Epidemiology Collaboration developed a new equation in 2009 that was more accurate than the MDRD Study equation at values above 60 mL/min/1.73 m. As of 2017, reporting eGFR with creatinine is almost universal in many countries. A reference system for cystatin C became available in 2010, and manufacturers are in the process to standardize cystatin C assays. Equations for eGFR based on standardized cystatin C alone and with creatinine are now available from the Chronic Kidney Disease Epidemiology Collaboration and other groups.
2002 年,肾脏病预后质量倡议指南建议临床实验室在每次报告肌酐结果时报告估算肾小球滤过率(eGFR),以帮助临床医生识别早期慢性肾脏病患者。当时,建议使用基于血清肌酐测量的原始肾脏病饮食改良研究(MDRD)方程来计算 eGFR。由于 MDRD 研究方程是使用非标准化肌酐方法开发的,因此大约在 2010 年成立了国家肾脏病教育计划的一个实验室工作组,对来自全球制造商的所有肌酐方法进行标准化校准溯源。开发了一种用于标准化肌酐的改良 MDRD 研究方程。慢性肾脏病流行病学合作组织在 2009 年开发了一个新方程,该方程在 60ml/min/1.73m 以上的值上比 MDRD 研究方程更准确。截至 2017 年,许多国家几乎普遍使用肌酐报告 eGFR。胱抑素 C 的参考系统于 2010 年问世,制造商正在标准化胱抑素 C 检测。基于标准化胱抑素 C 单独和与肌酐的 eGFR 方程现在可从慢性肾脏病流行病学合作组织和其他组织获得。